NFE2L2 and monoclonal gammopathy: Nrf2 transcript levels were significantly lower in patients with MM, compared with the corresponding levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and in healthy donors (p < 0.001; Fig. 3a).